ISTH 2024 marks the 32nd Congress of the esteemed International Society on Thrombosis and Haemostasis (ISTH), set to take place in Bangkok, Thailand from June 22-26th. As the premier global organization dedicated to advancing the understanding, prevention, diagnosis, and treatment of conditions related to thrombosis and hemostasis, ISTH brings together over 7,000 clinicians, researchers, and educators from more than 100 countries.

Before proceeding, we strongly encourage you to register for the event by clicking here. This will allow you to secure accommodations, access travel information, plan your schedule, and reserve your spot for networking events before they reach capacity.

Highlighted below are some of the key sessions at ISTH 2024 focusing on venous thromboembolism (VTE), encompassing topics such as cancer-associated thrombosis and acute interventional management. These sessions are organized in chronological order for your convenience.

Saturday, June 22, 2024

  • Time: 13:00 – 13:15 ICT
  • Title: VTE predictors and diagnosis
  • Room: Ballroom B4
  • Time: 13:45 – 14:00 ICT
  • Title: The Vienna CATScore for predicting VTE risk in patients with cancer: an external validation across multiple time-points
  • Room:Ballroom B3
  • Time: 14:00 – 14:15 ICT
  • Title: Successful development of an electronic nose utilizing blood and urine metabolomics for the prediction of lower extremity deep venous thrombosis
  • Room:Ballroom B4

Sunday, June 23, 2024

  • Time: 08:00 – 09:15 ICT
  • Title: Acute interventional management in VTE (UIP joint session)
  • Room:Plenary Hall
  • Time: 09:45 – 10:00 ICT
  • Title: Activated FXI-antithrombin complex predicts venous thromboembolism (VTE) in a large prospective cohort of non-small cell lung cancer (NSCLC) patients
  • Room:Ballroom B2
  • Time: 16:50 – 17:00 ICT 
  • Title: Understanding the racial disparities in the diagnosis and outcomes of postpartum VTE
  • Room: 110 A-C

Monday, June 24, 2024

  • Time: 08:25 – 08:45 ICT
  • Title: Risk assessment and prevention for cancer-associated VTE
  • Room: Plenary Hall
  • Time: 13:45 – 14:45 ICT 
  • Title: Acute phase reactants proteins (APRPs) in COVID-19: association with VTE and mortality.
  • Room: Exhibition Hall
  • Time: 17:45 – 18:05 ICT  
  • Title: Update from VTE Risk Factors and Thromboprophylaxis Working Party
  • Room: Ballroom B4

Tuesday, June 25, 2024

  • Time: 09:30 – 10:45 ICT
  • Title: Improving outcomes in VTE
  • Room:Ballroom B2
  • Time: 09:45 – 10:00 ICT 
  • Title: Risk of bleeding and performance of bleeding risk scores in patients with venous thromboembolism on anticoagulation: Results from a prospective cohort study
  • Room: Ballroom B2
  • Time: 10:30 – 10:45 ICT
  • Title: Incidence and predictors of venous thromboembolisms in ambulatory patients: a retrospective analysis of 43 906 same-day-emergency-care attendances using electronic health records
  • Room:Ballroom B4

Wednesday, June 26, 2024

  • Time: 08:30 – 08:50 ICT 
  • Title: New targets for antithrombotic drugs
  • Room: Ballroom B1

Venous thromboembolism is a key topic that will be discussed at the ISTH 2024 conference. In addition, the event will feature presentations on the latest developments in hemophilia and bleeding disorders, the influence of artificial intelligence, long-term monitoring of gene therapy outcomes, and many other important topics. This conference promises to be a valuable educational opportunity, and we are excited to welcome you there!

Sign up for alerts and stay informed on the latest published guidelines and articles.

Copyright © 2024 Guideline Central, All rights reserved.